Comparison of the biopsy growth assay in heart transplant patients on cyclosporine vs. FK506 immunosuppressant
M Chen-Woan(University of Pittsburgh Medical Center), René J. Duquesnoy(University of Pittsburgh Medical Center), J. Fricker, Robert L. Kormos(Abbott Northwestern Hospital), B. Griffith(University of Maryland Medical Center), A. Zeevi, Christina L. Kaufman(University of Louisville), Tony R. Zerbe(University of Pittsburgh), James M. Armitage(ASL Environmental Sciences (Canada))
Cited by 0
Related Papers
PFAS Exposure Pathways for Humans and Wildlife: A Synthesis of Current Knowledge and Key Gaps in Understanding
|Environmental Toxicology and Chemistry|2020|782
Use of an Intrapericardial, Continuous-Flow, Centrifugal Pump in Patients Awaiting Heart Transplantation
|Circulation|2012|655
Rates and Risk Factors for Nonadherence to the Medical Regimen After Adult Solid Organ Transplantation
|Transplantation|2007|575
An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial
|The Journal of Heart and Lung Transplantation|2013|461
The International Registry on Hand and Composite Tissue Transplantation
|Transplantation|2008|410